Document is current
Any future updates will be listed below
-
Authors
Zhu, Yining https://orcid.org/0000-0002-7178-0097
Yao, Zhi-Cheng
Li, Shuyi
Ma, Jingyao
Wei, Christine https://orcid.org/0009-0005-0831-6813
Yu, Di
Stelzel, Jessica L. https://orcid.org/0000-0002-5644-9240
Ni, Bobby Y. X.
Miao, Yang
Van Batavia, Kyra https://orcid.org/0009-0006-5419-9221
Lu, Xiaoya
Lin, Jinghan
Dai, Yifan https://orcid.org/0000-0001-7897-5228
Kong, Jiayuan
Shen, Ruochen https://orcid.org/0000-0001-9967-4758
Goodier, Kailei D.
Liu, Xiang
Cheng, Leonardo
Vuong, Ivan
Howard, Gregory P.
Livingston, Natalie K.
Choy, Joseph https://orcid.org/0000-0001-6282-9437
Schneck, Jonathan P. https://orcid.org/0000-0001-5346-2776
Doloff, Joshua C. https://orcid.org/0000-0002-4323-3264
Reddy, Sashank K.
Hickey, John W.
Mao, Hai-Quan https://orcid.org/0000-0002-4262-9988
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01AI155313)
U.S. Department of Health & Human Services | National Institutes of Health (P41EB028239, R01CA293906)
- License Information
-
More Information
Article History
Received: 21 January 2025
Accepted: 18 June 2025
First Online: 1 July 2025
Competing interests
: H.-Q.M., Y.Z., J.M., Z.C.Y. and C.W. are co-inventors of a pending patent application covering the LiNx formulation described in this paper, filed in April 2024 through and managed by Johns Hopkins Technology Ventures. The other authors declare no competing interests.
